Haematological cancer: Lenalidomide improves survival after ASCT
Sign Up to like & getrecommendations! Published in 2017 at "Nature Reviews Clinical Oncology"
DOI: 10.1038/nrclinonc.2017.135
Abstract: The outcomes of a phase II, single-arm study involving patients with microsatellite-unstable (MSI) metastatic colorectal cancer receiving treatment with nivolumab reveal high levels of effectiveness. In a heavily pretreated population, 23 patients (31% of the… read more here.
Keywords: survival asct; improves survival; haematological cancer; cancer ... See more keywords